Ticker · CUSIP 302941109
Holders (tracked)
13
Combined shares
2,316,662
Combined value
$395.76M
Last close
$179.50
Quarter
2025Q4
Price · 1Y$179.50+14.23 (+8.61%)H $184.51 · L $151.68 · Avg Vol 378K
Congress buyCongress sell
Tracked holders · last 8 quarters
+1 vs previous quarter over the last 8.
Price is +5.1% vs the avg quarter-end implied price across tracked holders.
SEC event timeline
23 events
- D.E. Shaw & Co. trimmed2026-02-17−8,517 shares · 2025Q4Position
- Ken Griffin (Citadel Advisors) trimmed2026-02-17−4,542 shares · 2025Q4Position
- Izzy Englander (Millennium Mgmt) trimmed2026-02-17−108,374 shares · 2025Q4Position
- Steve Cohen (Point72) trimmed2026-02-17−121,171 shares · 2025Q4Position
- T. Rowe Price added2026-02-17+13,840 shares · 2025Q4Position
- Two Sigma Investments trimmed2026-02-17−72,078 shares · 2025Q4Position
- Jeremy Grantham (GMO) trimmed2026-02-17−118,535 shares · 2025Q4Position
- AQR Capital Management added2026-02-17+107,181 shares · 2025Q4Position
- −11,216 shares · 2025Q4Position
- Renaissance Technologies trimmed2026-02-12−143,900 shares · 2025Q4Position
- Norges Bank (Norway SWF) opened position2026-02-10+357,883 shares · 2025Q4Position
- Two Sigma Investments added2025-11-14+191,885 shares · 2025Q3Position
- Izzy Englander (Millennium Mgmt) trimmed2025-11-14−13,499 shares · 2025Q3Position
- D.E. Shaw & Co. trimmed2025-11-14−17,751 shares · 2025Q3Position
- AQR Capital Management trimmed2025-11-14−46,248 shares · 2025Q3Position
- Steve Cohen (Point72) opened position2025-11-14+342,290 shares · 2025Q3Position
- T. Rowe Price added2025-11-14+281,626 shares · 2025Q3Position
- Jeremy Grantham (GMO) added2025-11-13+2,699 shares · 2025Q3Position
- Norges Bank (Norway SWF) exited2025-11-13−402,720 shares · 2025Q3Position
- +12,635 shares · 2025Q3Position
- Renaissance Technologies trimmed2025-11-13−49,500 shares · 2025Q3Position
- Norges Bank (Norway SWF) trimmed2025-11-12−5,006 shares · 2024Q3Position
- Baillie Gifford & Co exited2025-10-31−6,735 shares · 2025Q3Position
Insider activity
No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of FCN…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
| Investor | First in | Cost basis | Return | Position value today |
|---|---|---|---|---|
| Ray Dalio (Bridgewater Associates) | 2021Q1 | $158.90 | +13.0% | $255K |
| Ken Griffin (Citadel Advisors) | 2016Q2 | $161.68 | +11.0% | $269K |
| Ken Griffin (Citadel Advisors) | 2016Q2 | $161.68 | +11.0% | $269K |
| Ken Griffin (Citadel Advisors) | 2016Q2 | $161.68 | +11.0% | $269K |
| Steve Cohen (Point72) | 2018Q2 | $161.87 | +10.9% | $39.7M |
| Two Sigma Investments | 2016Q1 | $162.04 | +10.8% | $25.2M |
| Izzy Englander (Millennium Mgmt) | 2016Q1 | $166.82 | +7.6% | $8.6M |
| Norges Bank (Norway SWF) | 2016Q1 | $167.71 | +7.0% | $64.2M |
| D.E. Shaw & Co. | 2016Q1 | $169.35 | +6.0% | $77.0M |
| AQR Capital Management | 2016Q1 | $169.76 | +5.7% | $50.0M |
| Renaissance Technologies | 2016Q1 | $171.48 | +4.7% | $9.5M |
| Jeremy Grantham (GMO) | 2018Q2 | $174.44 | +2.9% | $30.6M |
| T. Rowe Price | 2016Q1 | $174.73 | +2.7% | $94.3M |
Who moved on this name in 2025Q4
Position changes reported for the latest quarter, grouped by direction.
New positions1
- Norges Bank (Norway SWF)+357,883$61.1M
Added to2
- AQR Capital Management+107,181$18.3M
- T. Rowe Price+13,840$2K
Trimmed8
- Renaissance Technologies−143,900$24.6M
- Steve Cohen (Point72)−121,171$20.7M
- Jeremy Grantham (GMO)−118,535$20.2M
- Izzy Englander (Millennium Mgmt)−108,374$18.5M
- Two Sigma Investments−72,078$12.3M
- Ray Dalio (Bridgewater Associates)−11,216$1.9M
- D.E. Shaw & Co.−8,517$1.5M
- Ken Griffin (Citadel Advisors)−4,542$776K
Exited0
—
Institutional ownership over time
Distinct super-investors holding this ticker · combined dollar value, by quarter.
| Quarter | Holders | Combined value |
|---|---|---|
| 2022Q1 | 10 | $48.20B |
| 2022Q2 | 13 | $53.89B |
| 2022Q3 | 16 | $668.8M |
| 2022Q4 | 14 | $645.6M |
| 2023Q1 | 14 | $789.6M |
| 2023Q2 | 14 | $815.5M |
| 2023Q3 | 13 | $826.4M |
| 2023Q4 | 12 | $938.0M |
| 2024Q1 | 13 | $1.06B |
| 2024Q2 | 14 | $1.12B |
| 2024Q3 | 12 | $490.1M |
| 2024Q4 | 12 | $276.9M |
| 2025Q1 | 11 | $308.6M |
| 2025Q2 | 12 | $456.9M |
| 2025Q3 | 12 | $392.3M |
| 2025Q4 | 13 | $395.8M |
Congress members trading this stock
| Date | Member | Type | Amount range | Filing |
|---|---|---|---|---|
| 2025-09-11 | Lisa McClain | Sell | $1K – $15K | PDF ↗ |
| 2025-08-13 | Lisa McClain | Buy | $1K – $15K | PDF ↗ |
Who owns FCN
13 super-investors · 2025Q4
Tracked stake
2.32M
shares
Combined value
$396M
% of shares outstanding
—
shares-out unknown
Quarter action mix
New1Added2Trim10
| # | Manager | Shares | Value |
|---|---|---|---|
| 1 | T. Rowe Price | 525.6K | $90M |
| 2 | D.E. Shaw & Co. | 429.1K | $73M |
| 3 | Norges Bank Norway SWF | 357.9K | $61M |
| 4 | AQR Capital Management | 278.7K | $48M |
| 5 | Steve Cohen Point72 | 221.1K | $38M |
| 6 | Jeremy Grantham GMO | 170.3K | $29M |
| 7 | Two Sigma Investments | 140.3K | $24M |
| 8 | Ken Griffin Citadel Advisors | 78.6K | $13M |
| 9 | Renaissance Technologies | 52.8K | $9M |
| 10 | Izzy Englander Millennium Mgmt | 47.9K | $8M |
| 11 | Ken Griffin Citadel Advisors | 11.4K | $2M |
| 12 | Ken Griffin Citadel Advisors | 1.5K | $256K |
| 13 | Ray Dalio Bridgewater Associates | 1.4K | $242K |
Recent moves
20 transactions
- −72,078 · 2025Q4
- +13,840 · 2025Q4
- TRIMD.E. Shaw & Co.−8,517 · 2025Q4
- −118,535 · 2025Q4
- −121,171 · 2025Q4
- +107,181 · 2025Q4
- −108,374 · 2025Q4
- −4,542 · 2025Q4
- −11,216 · 2025Q4
- −143,900 · 2025Q4
- +357,883 · 2025Q4
- +342,290 · 2025Q3
- +191,885 · 2025Q3
- −46,248 · 2025Q3
- TRIMD.E. Shaw & Co.−17,751 · 2025Q3
- −13,499 · 2025Q3
- +281,626 · 2025Q3
- −49,500 · 2025Q3
- +12,635 · 2025Q3
- −402,720 · 2025Q3
Embed this chart
Paste this iframe anywhere to embed the live FCN chart.
<iframe src="https://openstocks.me/embed/stocks/FCN" width="100%" height="480" frameborder="0" loading="lazy" title="FCN chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>Explore related topics
- FCN insider tradingEvery Form 4 filing by FCN officers, directors, and 10%+ holders.
- FCN analyst target pricesWall Street consensus target, analyst-by-analyst breakdown, and revision history.
- Most popular hedge-fund stocksSee where this ticker ranks against the broader smart-money consensus.
- All insider tradingCross-ticker view of where corporate insiders are buying on the open market.
- Congress stock tradesReal-time PTR disclosures filed under the STOCK Act.
- Smart-money signalsComposite signals where institutional, insider and Congress flows converge.